#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyloidosis Myelodysplastic syndrome Erythema multiforme Dilated cardiomyopathy Choroid melanoma Osteosarcoma recurrent Leiomyosarcoma Spinal muscular atrophy Asthma Kaposi's sarcoma Small intestine neuroendocrine tumour Neuroblastoma recurrent Pemphigoid Anal cancer recurrent Cystic fibrosis gastrointestinal disease More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III – Treatment Angiosarcoma metastatic – Life with Disease Angiosarcoma – Life with Disease Sarcoidosis Medulloblastoma – Life with Disease Haemophilia B with anti factor IX Hereditary ataxia – Treatment Idiopathic inflammatory myopathy – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Fragile X syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    H2-Receptor Antagonist Daptomycin Hydroxi-Methionine Calcium Doxylamine Hydrogen Succinate Gadobenate Dimeglumine Betula Verrucosa (108) Gallium (68Ga) Psma-R2 Calcium Chloride Hexahydrate Dabigatran Sacituzumab Tirumotecan Bemcentinib Nanatinostat Vibostolimab Erythromycin Lactobionate Warfarin Sodium Tebipenem Pivoxil Hydrobromide Ethinylestradiol Clonazepam Adalimumab ISPAGHULA HUSK More therapies…

    Learn about Your Condition

    Hyperadrenocorticism Small cell lung cancer Varicella Fibrosarcoma metastatic Biliary adenoma Dry eye Oropharyngeal cancer recurrent Heart transplant Chronic hepatic failure Bone sarcoma Alcoholic liver disease Prostate cancer recurrent Arteriosclerosis Lymphangiosarcoma Infant sedation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Safety and Effects of Infusing Modified CD34+ Cells for Patients with Fanconi Anemia Subtype A

    Recruiting

    1 1 1
    Investigated Diseases:
    • Congenital aplastic anaemia
    Investigated Drugs:
    • Autologous Cd34+Enriched Cells From Patients With Fanconi Anemia Subtype A Transduced Ex Vivo With Lentiviral Vector Carrying The Fanconi Anemia Complementation Group A Gene
    Spain

  • Study on Long-Term Safety of Pelabresib for Patients with Myelofibrosis or Essential Thrombocythemia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myeloproliferative neoplasm
    • Myelofibrosis
    Investigated Drugs:
    • 2-((4S)-6-(4-Chlorophenyl)-1-Methyl-4H-Benzo[C]Isoxazolo[4,5-E]Azepin-4-Yl)Acetamide Monohydrate
    Belgium Italy The Netherlands

  • Study on Amiodarone for Patients with Persistent Atrial Fibrillation Undergoing Electrical Cardioversion

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amiodarone Hydrochloride
    Spain

  • Study on the Effects of Cyclosporine A in Patients with Takotsubo Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • Stress cardiomyopathy
    Investigated Drugs:
    • Ciclosporin
    • Sodium Chloride
    Germany

  • Study on the Effects of Atezolizumab, Bevacizumab, Oxaliplatin, and Capecitabine in Patients with Colorectal Cancer and Liver Metastasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    • Metastases to liver
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Capecitabine
    France

  • Study on Senicapoc for Patients with Progressive Fibrotic Interstitial Lung Disease to Prevent Disease Progression

    Recruiting

    2 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Senicapoc
    • Placebo
    Denmark Estonia
Previous Page
1 … 354 355 356 357 358 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!